Telemedicine represents the practical embodiment of patient-centred oncology care, a concept that has become increasingly popular in the past few years. Yet despite the demonstrated benefits of telemedicine, its longitudinal adoption remains limited. Herein we discuss some of the potential challenges that telemedicine faces, as we underutilize this approach relative to its anticipated value.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bradbury, A. et al. Utilizing remote real-time videoconferencing to expand access to cancer genetic services in community practices: a multicenter feasibility study. J. Med. Internet Res. 18, e23 (2016).
Lally, K., Kematick, B. S., Gorman, D. & Tulsky, J. Rapid conversion of a palliative care outpatient clinic to telehealth. JCO Oncol. Pract. 17, e62–e67 (2021).
Cox, A. et al. Cancer survivors’ experience with telehealth: a systematic review and thematic synthesis. J. Med. Internet Res. 19, e11 (2017).
Patel, K. B. et al. Estimated indirect cost savings of using telehealth among nonelderly patients with cancer. JAMA Netw. Open 6, e2250211 (2023).
Shaverdian, N. et al. Impact of telemedicine on patient satisfaction and perceptions of care quality in radiation oncology. J. Natl. Compr. Canc. Netw. 19, 1174–1180 (2021).
Patel, K. B. et al. Telemedicine adoption in an NCI-designated cancer center during the COVID-19 pandemic: a report on patient experience of care. J. Natl. Compr. Canc. Netw. 21, 496–502.e6 (2023).
Gergen Barnett, K. et al. Telehealth’s double-edged sword: bridging or perpetuating health inequities? J. Gen. Intern. Med. 37, 2845–2848 (2022).
Tevaarwerk, A. J. et al. Oncologist perspectives on telemedicine for patients with cancer: a National Comprehensive Cancer Network survey. JCO Oncol. Pract. 17, e1318–e1326 (2021).
West, H. J., Barzi, A. & Wong, D. Telemedicine in cancer care beyond the COVID-19 pandemic: oncology 2.0? Curr. Oncol Rep. 24, 1843–1850 (2022).
West, H. J. For those who participate in multispecialty cancer conferences (a.k.a. tumor boards) that converted from in person to virtual (Zoom, Teams, etc.) in the face of the pandemic, what are you now doing as the “new normal”? #MedTwitter #OncTwitter. twitter, https://twitter.com/JackWestMD/status/1620452640055492614 (accessed 12 May 2023).
Acknowledgements
E.B. and F.C. receive support from the NIH/NCI (Grant P30 CA008748). E.B. receives support from the NCI MATCHES P50 Grant (P50 CA271357).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.J.W. and F.C. declare no competing interests. E.B. has received consulting fees from Flatiron Health.
Rights and permissions
About this article
Cite this article
West, H.J., Bange, E. & Chino, F. Telemedicine as patient-centred oncology care: will we embrace or resist disruption?. Nat Rev Clin Oncol 20, 659–660 (2023). https://doi.org/10.1038/s41571-023-00796-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-023-00796-5